EMMA ARGUETA: Open Payments
NPI 1194439943 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 41 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $453 · 2025 $1,057
Food & beverage: $984Education: $74
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $189 |
| Regeneron Healthcare Solutions, Inc. | 5 | $170 |
| AstraZeneca Pharmaceuticals LP | 5 | $150 |
| Genentech USA, Inc. | 3 | $88 |
| ABIOMED | 3 | $81 |
| CSL Behring | 3 | $70 |
| GENZYME CORPORATION | 2 | $56 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Incyte Corporation | 2 | $41 |
Products named: DUPIXENT, Rhapsido, TEZSPIRE, Xolair, Hizentra, LEQVIO, AIRSUPRA, NEFFY.
Industry payments across NM — which companies pay providers there.
